Australia markets closed

Genocea Biosciences, Inc. (GBI1.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
0.04700.0000 (0.00%)
At close: 09:50PM CEST
Currency in EUR

Valuation measures4

Market cap (intra-day) 917.79k
Enterprise value -3.43M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)1.84
Price/book (mrq)0.24
Enterprise value/revenue -1.80
Enterprise value/EBITDA 0.10

Trading information

Stock price history

Beta (5Y monthly) 21.81
52-week change 3-97.45%
S&P500 52-week change 326.49%
52-week high 31.9600
52-week low 30.0465
50-day moving average 30.3930
200-day moving average 30.9930

Share statistics

Avg vol (3-month) 38.86k
Avg vol (10-day) 316.24k
Shares outstanding 558.78M
Implied shares outstanding 6N/A
Float 858.75M
% held by insiders 10.00%
% held by institutions 10.02%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:8
Last split date 322 May 2019

Financial highlights

Currency in USD.

Fiscal year

Fiscal year ends 31 Dec 2021
Most-recent quarter (mrq)31 Mar 2022

Profitability

Profit margin 0.00%
Operating margin (ttm)-5,841.85%

Management effectiveness

Return on assets (ttm)-57.59%
Return on equity (ttm)-525.78%

Income statement

Revenue (ttm)1.91M
Revenue per share (ttm)0.03
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -55.67M
Net income avi to common (ttm)-37.19M
Diluted EPS (ttm)-0.5060
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)20.14M
Total cash per share (mrq)0.34
Total debt (mrq)15.48M
Total debt/equity (mrq)125.03%
Current ratio (mrq)1.35
Book value per share (mrq)0.21

Cash flow statement

Operating cash flow (ttm)-48.19M
Levered free cash flow (ttm)-31.45M